Clinical Trial Update: Trial of BMS-986012 in Combination With Platinum and Etoposide [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating the investigational antibody BMS-986012 in combination with a platinum agent and etoposide fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• BMS-986012
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Small Cell Lung Cancer | Phase 1 | Status: COMPLETED